Financial reports
10-Q
2013 Q1
Quarterly report
14 May 13
10-K/A
2012 FY
Annual report (amended)
30 Apr 13
10-K
2012 FY
Annual report
15 Mar 13
10-K/A
2011 FY
Annual report (amended)
31 Jan 13
10-Q
2012 Q3
Quarterly report
31 Jan 13
NT 10-Q
Notice of late quarterly filing
23 Nov 12
NT 10-Q
Notice of late quarterly filing
9 Nov 12
10-Q
2012 Q2
Quarterly report
9 Aug 12
Current reports
8-K
Bankruptcy or Receivership
2 Jul 13
8-K
Entry into a Material Definitive Agreement
17 Jun 13
8-K
Entry into a Material Definitive Agreement
7 Jun 13
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
29 May 13
8-K
Entry into a Material Definitive Agreement
20 May 13
8-K/A
Unigene Announces First Quarter 2013 Financial Results and Provides Corporate Update
17 May 13
8-K
Unigene Announces First Quarter 2013 Financial Results and Provides Corporate Update
14 May 13
8-K
Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs
13 May 13
8-K
Entry into a Material Definitive Agreement
1 May 13
8-K
Victory Park Capital Completes Public Auction of Unigene’s
23 Apr 13
Registration and prospectus
D
$750K in debt, sold $750K, 1 investor
22 Apr 13
S-1
IPO registration
19 Oct 12
D
$7.5M in debt, sold $4M, 4 investors
9 Oct 12
8-A12G/A
Registration of securities (amended)
26 Sep 12
424B3
Prospectus supplement
4 Aug 11
POS AM
Prospectus update (post-effective amendment)
23 Mar 11
424B3
Prospectus supplement
14 Feb 11
424B3
Prospectus supplement
8 Feb 11
424B3
Prospectus supplement
13 Dec 10
424B3
Prospectus supplement
10 Nov 10
Proxies
PRE 14A
Preliminary proxy
19 Nov 12
DEF 14A
Definitive proxy
21 Apr 11
DEF 14A
Definitive proxy
29 Apr 10
DEFA14A
Additional proxy soliciting materials
29 Apr 10
PRE 14A
Preliminary proxy
19 Apr 10
DEFA14A
Additional proxy soliciting materials
17 Mar 10
DEFA14A
Additional proxy soliciting materials
3 Jun 09
DEF 14A
Definitive proxy
29 Apr 09
DEF 14A
Definitive proxy
28 Apr 08
DEF 14A
Definitive proxy
30 Apr 07
Other
REVOKED
Registration or securities revoked
1 Jul 19
CT ORDER
Confidential treatment order
15 May 12
CT ORDER
Confidential treatment order
12 Dec 11
EFFECT
Notice of effectiveness
21 Apr 11
CORRESP
Correspondence with SEC
20 Apr 11
CT ORDER
Confidential treatment order
20 Apr 11
CORRESP
Correspondence with SEC
18 Apr 11
UPLOAD
Letter from SEC
13 Apr 11
UPLOAD
Letter from SEC
30 Mar 11
CORRESP
Correspondence with SEC
25 Mar 11
Ownership
SC 13D/A
Unigene Laboratories Inc
13 Jun 13
SC 13D/A
Unigene Laboratories Inc
24 May 13
SC 13D/A
Victory Park Capital Advisors, LLC
3 May 13
SC 13D/A
Victory Park Capital Advisors, LLC
12 Apr 13
SC 13D/A
Victory Park Capital Advisors, LLC
5 Oct 12
SC 13D/A
Victory Park Capital Advisors, LLC
19 Jul 12
SC 13D/A
Victory Park Capital Advisors, LLC
8 Jun 12
SC 13D/A
WYNNEFIELD PARTNERS SMALL CAP VALUE LP
29 May 12
SC 13D/A
Victory Park Capital Advisors, LLC
11 Jul 11
SC 13D/A
Victory Park Capital Advisors, LLC
26 Jan 11